MigraineScience
Thu, Sep 05, 24
A Breakthrough on the Horizon: PACAP-Targeting Antibodies Offer New Promise for Migraine Prevention
Migraine patients may soon have a new treatment option. Recent clinical trials show promising results for Lu AG09222, a monoclonal antibody targeting PACAP, a neuropeptide involved in migraine pathophysiology.
Read More